| Literature DB >> 35140481 |
Raed Ennab1, Waleed Al-Momani2, Rama Al-Titi2, Ayah Elayan2.
Abstract
BACKGROUND: Surgical site infections are hospital-acquired, vary from one hospital to another, and can cause significant postoperative morbidity, mortality, and prolonged hospital stay.Entities:
Keywords: antimicrobial susceptibility; bacterial isolation; bacterial resistance; multidrug resistance; surgical site infection; wound swab
Year: 2022 PMID: 35140481 PMCID: PMC8818773 DOI: 10.2147/IDR.S350406
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Distribution of Bacterial Isolates with the Type of Surgery from Surgical Site Infections in Public Hospitals in Northern Jordan
| Bacteria | Bed Sore | Diabetic Foot | Fracture | Tonsils | Gun Shot | Trauma | Colectomy | No. of Isolates | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | F | M | F | M | F | M | F | M | F | M | F | M | F | ||
| 2 | 0 | 1 | 2 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 1 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 0 | 0 | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 8 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | |
| 6 | 9 | 2 | 6 | 1 | 3 | 1 | 28 | ||||||||
Abbreviations: M, male; F, female.
Antibiotic Profile of the Isolated Bacteria from Surgical Site Infections in Public Hospitals in Northern Jordan
| Antibiotic | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S | R | I | S | R | I | S | R | I | S | R | I | S | R | I | S | R | I | S | R | I | S | R | I | |
| 2 | 0 | 0 | 5 | 2 | 1 | 1 | 0 | 0 | 3 | 0 | 0 | 4 | 0 | 0 | 1 | 0 | 0 | 5 | 3 | 0 | 1 | 0 | 0 | |
| 1 | 1 | 0 | 4 | 4 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 1 | 3 | 0 | 1 | 0 | 0 | 1 | 7 | 0 | 1 | 0 | 0 | |
| 2 | 0 | 0 | 5 | 2 | 1 | 1 | 0 | 0 | 2 | 1 | 0 | 4 | 0 | 0 | 1 | 0 | 0 | 5 | 3 | 0 | 1 | 0 | 0 | |
| N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | 0 | 1 | 0 | 4 | 4 | 0 | 1 | 0 | 0 | |
| 2 | 0 | 0 | 6 | 2 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 3 | 1 | 0 | 1 | 0 | 0 | 8 | 0 | 0 | 1 | 0 | 0 | |
| 2 | 0 | 0 | 7 | 1 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 3 | 1 | 0 | 1 | 0 | 0 | 5 | 3 | 0 | 1 | 0 | 0 | |
| 2 | 0 | 0 | 4 | 4 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 4 | 0 | 0 | 0 | 1 | 0 | 5 | 3 | 0 | 1 | 0 | 0 | |
| N | N | N | N | N | N | N | N | N | N | N | N | N | N | N | 1 | 0 | 0 | 7 | 1 | 0 | 1 | 0 | 0 | |
| 2 | 0 | 0 | 4 | 4 | 0 | 1 | 0 | 0 | 0 | 3 | 0 | 3 | 0 | 1 | 1 | 0 | 0 | 4 | 4 | 0 | 0 | 1 | 0 | |
| 2 | 0 | 0 | 5 | 3 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 3 | 1 | 0 | 1 | 0 | 0 | 5 | 3 | 0 | 1 | 0 | 0 | |
| 0 | 2 | 0 | 2 | 6 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 4 | 0 | 0 | 1 | 0 | 0 | 2 | 6 | 0 | 0 | 1 | 0 | |
| 2 | 0 | 0 | 4 | 4 | 0 | 1 | 0 | 0 | 0 | 3 | 0 | 3 | 1 | 0 | 1 | 0 | 0 | 5 | 3 | 0 | 1 | 0 | 0 | |
| 0 | 2 | 0 | 6 | 2 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 4 | 0 | 0 | 1 | 0 | 4 | 4 | 0 | 1 | 0 | 0 | |
Abbreviations: S, sensitive; R, resistant; I, intermediate; N, not applicable; CIP, ciprofloxacin; AML, ampicillin; NOR, norfloxacin; E, erythromycin; C, chloramphenicol; CN, gentamicin; TE, tetracycline; VA, vancomycin; AMC, amoxicillin/clavulanic acid; FEP, cefepime; P, penicillin; DA, clindamycin; SXT, trimethoprim/sulfamethoxazole; OX, oxacillin.
Multidrug Resistance Profile of the Isolated Bacteria to the Tested Antibiotics (N = 13)
| Parameter | Frequency | MAR Index | Parameter | Frequency | MAR Index |
|---|---|---|---|---|---|
| R3 = TE, E, OX | 1 | 0.23 | R3 = P, VA, OX | 1 | 0.25 |
| R4 = P, AML, VA, OX | 2 | 0.33 | |||
| R7 = P, AML, TE, VA, AMC, E, OX | 1 | 0.54 | R9 = P, AML, C, FEP, VA, SXT, CN, E, OX | 1 | 0.75 |
| R10 = AML, AMC, P, OX, FEP, SXT, CN, E, NOR, CIP | 2 | 0.77 | |||
| R11 = AML, AMC, P, OX, TE, FEP, SXT, CN, E, NOR, CIP | 1 | 0.85 | R7 = AML, TE, P, VA, OX, SXT, AMC | 1 | 0.58 |
| R10 = AML, AMC, VA, P, OX, TE, FEP, SXT, CN, E | 1 | 0.83 | |||
| R8 = P, AML, TE, VA, SXT, AMC, E, OX | 1 | 0.66 | R11 = AML, AMC, VA, P, OX, TE, FEP, SXT, CN, E, NOR | 2 | 0.92 |
| R 9 = P, AML, TE, VA, SXT, AMC, E, OX, NOR | 1 | 0.75 | |||
| R 9 = P, AML, TE, VA, SXT, AMC, E, OX, C | 1 | 0.75 | R6 = AMC, P, TE, VA, E, OX | 1 | 0.50 |
Note: MAR index = multiple antibiotic resistance index = no. of antimicrobials to which the isolate is resistant/no. of antibiotics to which the isolate is subjected.
Abbreviations: CIP, ciprofloxacin; AML, ampicillin; NOR, norfloxacin; E, erythromycin; C, chloramphenicol; CN, gentamicin; TE, tetracycline; VA, vancomycin; AMC, amoxicillin/clavulanic acid; FEP, cefepime; P, penicillin; DA, clindamycin; SXT, trimethoprim/sulfamethoxazole; OX, oxacillin.